FI915841A - Bifenylylfoereningar. - Google Patents

Bifenylylfoereningar. Download PDF

Info

Publication number
FI915841A
FI915841A FI915841A FI915841A FI915841A FI 915841 A FI915841 A FI 915841A FI 915841 A FI915841 A FI 915841A FI 915841 A FI915841 A FI 915841A FI 915841 A FI915841 A FI 915841A
Authority
FI
Finland
Prior art keywords
bifenylylfoereningar
Prior art date
Application number
FI915841A
Other languages
English (en)
Other versions
FI915841A0 (fi
Inventor
Tibur Schmidlin
Franz Ostermayer
Peter Buehlmayer
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI915841A0 publication Critical patent/FI915841A0/fi
Publication of FI915841A publication Critical patent/FI915841A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI915841A 1990-12-14 1991-12-11 Bifenylylfoereningar. FI915841A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH396590 1990-12-14

Publications (2)

Publication Number Publication Date
FI915841A0 FI915841A0 (fi) 1991-12-11
FI915841A true FI915841A (fi) 1992-06-15

Family

ID=4267265

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915841A FI915841A (fi) 1990-12-14 1991-12-11 Bifenylylfoereningar.

Country Status (14)

Country Link
US (1) US5369110A (fi)
EP (1) EP0490820A3 (fi)
JP (1) JPH04300859A (fi)
KR (1) KR920012051A (fi)
AU (1) AU657498B2 (fi)
CA (1) CA2057511A1 (fi)
FI (1) FI915841A (fi)
HU (1) HUT59660A (fi)
IE (1) IE914358A1 (fi)
IL (1) IL100267A0 (fi)
MX (1) MX9102500A (fi)
NO (1) NO914926L (fi)
PT (1) PT99777B (fi)
ZA (1) ZA919837B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0528762T3 (da) * 1991-08-15 1997-08-25 Ciba Geigy Ag N-acyl-N-heterocyclyl- eller naphthylalkyl-aminosyrer som angiotensin II antagonister
US5312820A (en) * 1992-07-17 1994-05-17 Merck & Co., Inc. Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
US6307090B1 (en) 1999-01-22 2001-10-23 The United States Of America As Represented By The Department Of Health And Human Services Acylated oligopeptide derivatives having cell signal inhibiting activity
US7226991B1 (en) * 1999-03-23 2007-06-05 United States Of America, Represented By The Secretary, Department Of Health And Human Services Phenylalanine derivatives
JP4604161B2 (ja) * 1999-03-23 2010-12-22 アメリカ合衆国 フェニルアラニン誘導体
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
US7871981B2 (en) * 1999-10-22 2011-01-18 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of cell motility, angiogenesis, and metastasis
US7132392B1 (en) 1999-10-22 2006-11-07 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of cell motility and angiogenesis by inhibitors of Grb2-SH2-domain
US7425537B2 (en) * 2000-08-22 2008-09-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services SH2 domain binding inhibitors
US6977241B2 (en) * 2000-08-22 2005-12-20 The United States Of America As Represented By The Department Of Health & Human Services SH2 domain binding inhibitors
US20040138104A1 (en) * 2003-01-14 2004-07-15 The Government Of The United States Of America Represented By The Secretary, Peptides
US20050119163A1 (en) * 2003-09-18 2005-06-02 The Government Of The United States Of America, As Represented By The Secretary, SH2 domain binding inhibitors
DE102004060542A1 (de) 2004-12-16 2006-07-06 Sanofi-Aventis Deutschland Gmbh Hydroxybiphenyl-Carbonsäuren und Derivate, Verfahren zu deren Herstellung und deren Verwendung
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
EP2527360B1 (en) 2007-06-04 2015-10-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
KR101373705B1 (ko) 2011-08-05 2014-03-14 동국대학교 산학협력단 신규한 바이페닐 유도체 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 포함하는 염증성 질환 또는 자가면역질환의 예방 또는 치료용 약학적 조성물
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
GB202014589D0 (en) * 2020-09-16 2020-10-28 Ucl Business Ltd Agents for use in the treatment of amyloidosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3928177A1 (de) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL95975A (en) * 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
IL96019A0 (en) * 1989-10-31 1991-07-18 Fujisawa Pharmaceutical Co Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DE122010000024I1 (de) * 1990-02-19 2010-07-08 Novartis Ag Acylverbindungen
FR2677016A1 (fr) * 1991-05-31 1992-12-04 Union Pharma Scient Appl Nouveaux derives d'amide antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
EP0490820A2 (de) 1992-06-17
AU657498B2 (en) 1995-03-16
IL100267A0 (en) 1992-09-06
HU913952D0 (en) 1992-02-28
FI915841A0 (fi) 1991-12-11
HUT59660A (en) 1992-06-29
PT99777A (pt) 1992-12-31
US5369110A (en) 1994-11-29
NO914926L (no) 1992-06-15
KR920012051A (ko) 1992-07-25
AU8831891A (en) 1992-06-18
NO914926D0 (no) 1991-12-13
EP0490820A3 (en) 1992-10-28
ZA919837B (en) 1992-09-30
IE914358A1 (en) 1992-06-17
PT99777B (pt) 1999-05-31
JPH04300859A (ja) 1992-10-23
CA2057511A1 (en) 1992-06-15
MX9102500A (es) 1992-06-01

Similar Documents

Publication Publication Date Title
FI911037A (fi) Inhalationsanordning.
FI923572A (fi) Anordning foer enhetsdosering.
FI914685A (fi) Saekerhetstrokar.
NO913681D0 (no) Konstruksjonsleketoey.
FI915208A (fi) Styrrulle.
NO904665D0 (no) Altvaersdrakt.
FI915543A0 (fi) Pulverinhalator.
FI915841A (fi) Bifenylylfoereningar.
FI915350A0 (fi) Olefinpolymerisationskatalyt och -foerfaranden.
FI905009A (fi) Lyftanordning foer fartyg.
FI914509A0 (fi) Faerganordning foer en djuptrycksmaskin.
FI924291A0 (fi) Foertoejningssystem.
FI900436A (fi) Foerbraenningsanlaeggning.
FI913765A (fi) Fasthaollare foer draeneringsroer.
FI900572A0 (fi) Torrtoalettsystem.
FI915380A0 (fi) Braenslekomposition foer tvaotaktsmotor.
ATE124392T1 (de) 8-sulfamylmethylen-2-aminotetraline.
FI905324A0 (fi) Enzymatiskt bestaemningsfoerfarande foer aldoser.
FI920495A0 (fi) Pallbehaollare.
FI901498A0 (fi) Axelsystemkonstruktion foer nyttofordon.
FI911328A0 (fi) Povtagningsanordning.
FI901130A (fi) Massagearrangemang.
FI914206A (fi) Radaranordning.
DE59100113D1 (de) Rollcontainer.
FI902666A (fi) Undersoekningsfoerfarande och -anordning.

Legal Events

Date Code Title Description
FD Application lapsed